- Report
- October 2025
- 250 Pages
Global
From €3921EUR$4,490USD£3,406GBP
- Report
- October 2025
- 250 Pages
Global
From €3921EUR$4,490USD£3,406GBP
- Report
- August 2025
- 195 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- August 2025
- 198 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- August 2025
- 198 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- August 2025
- 187 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- August 2025
- 180 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- August 2025
- 185 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- September 2025
- 384 Pages
Global
From €5109EUR$5,850USD£4,438GBP
- Report
- September 2025
- 290 Pages
Global
From €5109EUR$5,850USD£4,438GBP
- Report
- August 2025
- 150 Pages
Global
From €2932EUR$3,358USD£2,547GBP
€3450EUR$3,950USD£2,997GBP
- Report
- April 2025
- 450 Pages
Global
From €3489EUR$3,995USD£3,031GBP
- Report
- September 2025
- 380 Pages
Global
From €4323EUR$4,950USD£3,755GBP
- Report
- August 2025
- 105 Pages
Global
From €2314EUR$2,650USD£2,010GBP
- Report
- July 2025
- 200 Pages
Global
From €3921EUR$4,490USD£3,406GBP
- Report
- August 2025
- 149 Pages
Global
From €2619EUR$2,999USD£2,275GBP
- Report
- August 2025
- 144 Pages
Global
From €2619EUR$2,999USD£2,275GBP
- Report
- January 2025
- 120 Pages
Global
From €5196EUR$5,950USD£4,514GBP
- Report
- December 2024
- 125 Pages
Global
From €5196EUR$5,950USD£4,514GBP
- Report
- August 2025
- 198 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP

The AIDS market within the context of Allergy and Immunology is focused on the development of treatments and therapies for HIV/AIDS. This includes the development of drugs to treat HIV infection, as well as vaccines and other therapies to prevent the spread of the virus. Additionally, research is being conducted to better understand the mechanisms of HIV infection and the development of new treatments.
The market is highly competitive, with many companies vying for a share of the market. Companies such as Gilead Sciences, Merck, GlaxoSmithKline, Bristol-Myers Squibb, and ViiV Healthcare are all major players in the AIDS market. Other companies such as AbbVie, Janssen, and Pfizer are also involved in the development of treatments and therapies for HIV/AIDS. Show Less Read more